SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires latest quarterly results have focused attention on a sharp increase in share repurchases, while weaker insurance performanceparticularly at GEICOdrew concern. Traders are split over whether the buybacks signal confidence and support the shares or whether insurance weakness and limited capital deployment remain a drag.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

XLF is drawing attention after a sharp financial-sector pullback and put-heavy options activity, prompting debate over whether traders are hedging or positioning for further weakness. Bearish concerns include credit exposure and rate pressures, while others view the decline as profit-taking within a still-resilient sector trend.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention amid weak, volatile price action around the 910-cent area, with traders debating whether it can hold support and break resistance or continue lower. Bulls point to a possible altcoin rebound and Algorands quantum-resistant and tokenization features, while bears cite its prolonged underperformance and see further downside.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the Florida Power and Light Company (FPL) and NextEra Energy Resources and NEET (NEER). The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEras planned Dominion acquisition and its push to expand power capacity for AI data centers are fueling debate. Bulls see greater scale and exposure to rising electricity demand, while skeptics point to financing and dilution risks, regulatory hurdles, and uncertainty over whether projected data-center loads will materialize.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,366,684,616.305855 in circulation. The last known price of Stellar is 0.15346137 USD and is down -1.11 over the last 24 hours. It is currently trading on 848 active market(s) with $109,670,947.94 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention for its persistent selloff and perceived underperformance, with traders debating whether broader crypto weakness and continued selling will push it lower or create a buying opportunity. Bulls point to Stellars institutional tokenization and payments developments, including DTCC-related plans, while skeptics argue that adoption has yet to translate into stronger token performance.

Vanguard World Fund - Vanguard Information Technology ETF

Vanguard Information Technology ETF

VGT is drawing attention amid volatility and a pullback in technology and AI-related stocks, with traders debating whether the weakness has further to run. Many are treating dips as a chance to add for long-term tech exposure, while others are waiting for a lower entry or warning of more downside.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Traders are debating whether enterprise AI will create implementation work for Accenture or erode its billable-hours consulting model, with concerns that pilots may not translate into funded production projects and that clients will press for lower fees. The discussion is bearish on technical resistance and short setups, while some point to the CEOs reported share purchase as a bullish counterpoint.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Quarterly results and RASONQUEs strong initial launch for metastatic pancreatic cancer are driving attention, with traders citing rapid patient uptake and upbeat analyst reactions. The bullish launch narrative is tempered by debate over high expectations, spending and the stocks volatile response to results.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing attention amid a sharp technology-sector pullback and worries that debt-funded AI and data-center spending may not deliver adequate returns; the funds concentration in major tech and chip stocks amplifies those concerns. Traders are watching heavy put activityuncertain whether it reflects hedging or bearish betswhile debating whether oversold conditions could support a bounce or whether further weakness lies ahead.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

A broad-market pullback and heightened volatility have put VOO in focus, with traders debating whether tech-led weakness and concerns about inflation, interest rates, and geopolitical risks signal a deeper downturn or a dip-buying opportunity. Many are adding to long-term positions, while others warn that the decline could continue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evogene Schedules Third Quarter 2026 Financial Results Release

Evogene Schedules Third Quarter 2026 Financial Results Release Evogene Schedules Third Quarter 2026 Financial Results ReleasePR NewswireREHOVOT, Israel, Nov. 5, 2026 Zoom conference call scheduled for November 19, 2026, 9:00 AM ETREHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq...

Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program

Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery ProgramPR NewswireREHOVOT, Israel, Oct...

Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain

Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in SpainPR NewswireREHOVOT, Israel, Oct. 26, 2026 Company to Attend BIO-Europe in Cologne, Germany, and...

Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL

Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeILPR NewswireREHOVOT, Israel, Oct. 20, 2026 The roadshow...

Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors

Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsPR NewswireREHOVOT, Israel, Oct. 6, 2026REHOVOT, Israel, Oct. 6...

Evogene Gets 180-day Nasdaq Extension To Regain Compliance

(RTTNews) - Israeli computational chemistry company Evogene Ltd. (EVGN), announced on Wednesday that it has received an additional 180 days from Nasdaq to regain compliance with the minimum $1 bid price requirement...

Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance

Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price CompliancePR NewswireREHOVOT, Israel, Sept. 30, 2026REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million.
AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards byread more...

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward PR Newswire REHOVOT, Israel, Aug. 31, 2026 Company urges shareholders to...

Evogene (EVGN) Q2 2026 Earnings Call Transcript

Evogene (EVGN) Q2 2026 Earnings Call Transcript...

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Evogene Ltd

Why Did EVGN Shares Drop More Than 14% Today?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>The proceeds are intended to be used for working capital and other general corporate purposes.</li><li>The computational chemistry company expects the transaction to close on or about Wednesday.&nbsp;</li><li>Earlier on Tuesday, the company announced an expanded collaboration with Google Cloud to integrate advanced AI agents into its ChemPass AI platform using Vertex AI.</li></ul>Shares of Evogene Ltd. (EVGN) fell more than 14% on Tuesday after the company announced that it had entered into a warrant inducement agreement with an existing institutional investor.The existing warrants would be exercised at a reduced price of $1.00 for total gross cash proceeds of approximately $3.4 million, before deducting financial advisor fees and other transaction expenses, the company said.The proceeds are intended to be used for working capital and other general corporate purposes.The computational chemistry company expects the transaction to close on or about Wednesday.<h2 class="st-heading-2">Deal Details</h2>Evogene said the transaction would include the immediate exercise of August 2024 Series A ordinary warrants to purchase up to 1,692,308 ordinary shares and August 2024 Series B ordinary warrants to purchase up to 1,692,308 ordinary shares.In return for these existing warrants being exercised, the investor will receive new unregistered warrants in a private placement, the company said. These new warrants will allow the purchase of up to 5,076,924 additional ordinary shares at an exercise price of $1.25 per share.The new Series A-1 warrants and the Series B-1 warrants will expire in five years and 18 months respectively. Both will be immediately exercisable upon issuance.<h2 class="st-heading-2">About Evogene</h2>Evogene is an Israel-based micro-cap computational chemistry company that specializes in the use of artificial intelligence (AI) for the discovery and development of life-science-based products.The company uses its proprietary ChemPass AI platform to generatively design novel, high-potency small molecules for pharma and agriculture.Earlier on Tuesday, the company announced an expanded collaboration with Google Cloud to integrate advanced AI agents into its ChemPass AI platform using Vertex AI.The deal aims to automate workflows, accelerate small-molecule discovery, improve accuracy and efficiency, and build on a prior generative AI model partnership to strengthen Evogene’s pharma and agriculture innovation pipeline.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/EVGN">EVGN shares</a> was in the ‘extremely bullish’ territory at the time of writing amid ‘extremely high’ message volumes.Shares of EVGN have declined more than 33% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/oracle-stock-rises-more-than-4.5-percent-to-one-week-high/cZbUghtR4pX">Oracle Stock Rises More Than 4.5% To One-Week High — Why Does Retail See A 'Solid Upside'?</a>

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Evogene on Tuesday announced that it had entered into a warrant inducement agreement for about  $3.4 million with an existing institutional investor. 

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$EVGN To everyone who contacted the SEC: Ofer Haviv and his team have destroyed all of Evogene's stock, it's in free fall, and Ofer Haviv has been spouting the same nonsense for years. It's time to contact the SEC; they need to investigate how Evogene is destroying its own shareholders.

Roberto

$EVGN Shot 50% on absolutely nothing... garden variety Israeli company P&D. $DFNS , at least there was some news b4 the dump. 
 
Sometimes the market just hands out money.

Brian Badtrader

$EVGN 🤝 

EcoPhage, a subsidiary of Evogene Ltd., signs a distribution agreement with Agricultura Nacional, S.A. de C.V. to distribute GoldenEco and EcoFire biopesticides in Mexico, subject to agreed commercial targets. 

Timely market event

Feed

News

Sentiment

Earnings

Fundamentals

Info

EVGN Evogene Ltd

Fundamentals

Latest EVGN News